Literature DB >> 26351497

Protective Effects of Hydrocortisone, Vitamin C and E Alone or in Combination against Renal Ischemia-Reperfusion Injury in Rat.

Omid Azari1, Reza Kheirandish2, Shahrzad Azizi2, Mohammad Farajli Abbasi3, Shahin Ghahramani Gareh Chaman3, Masoud Bidi3.   

Abstract

BACKGROUND: Renal ischemia reperfusion injury may occur in a variety of clinical situations, following a transient drop in total or regional blood flow to the kidney. This study was performed to investigate the protective effects of different antioxidants such as vitamin C, vitamin E, hydrocortisone and combination of these agents against experimental renal ischemia-reperfusion injury.
METHOD: Thirty male rats were divided into six groups. Group Sham, Group I/R: (45 min of ischemia followed by 1h of reperfusion), Group I/R+Vit C: (50 mg/kg Vit C, IV, immediately after reperfusion), Group I/R+Vit E: (20 mg/kg Vit E, IM, 15 min before reperfusion), Group I/R+Hydrocortisone: (50 mg/kg, IV, immediately after reperfusion), and Group Combination: Ischemia-reperfusion plus combination of Vit C, E and hydrocortisone. After the experiments, the left kidney was removed and the tissues were processed for histopathological examination. RESULT: Severe injuries such as necrosis of tubules, atrophy of glomerulus, and hemorrhage were observed in group I/R. Histological scores indicating tissue injury significantly decreased in all treatment groups compared to the group I/R. The renal tissue in group treatment was preserved in comparison with the group I/R. Comparison between the treatment groups showed that group combination was more effective and group vit E was less effective in protecting of renal tissue against I/R injuries.
CONCLUSION: The results demonstrated simultaneous administration of combination of Vit C, E and hydrocortisone before reperfusion of blood flow to the ischemic tissue could show a synergy against deleterious effects of I/R injuries in kidney.

Entities:  

Keywords:  Hydrocortisone; Ischemia; Kidney; Reperfusion; Vitamin C; Vitamin E

Year:  2015        PMID: 26351497      PMCID: PMC4539741     

Source DB:  PubMed          Journal:  Iran J Pathol        ISSN: 1735-5303


  32 in total

Review 1.  New developments in the treatment of ischemia/reperfusion injury.

Authors:  H K Ondiveeran; A Fox-Robichaud
Journal:  Curr Opin Investig Drugs       Date:  2001-06

Review 2.  The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist.

Authors:  John G Laffey; John F Boylan; Davy C H Cheng
Journal:  Anesthesiology       Date:  2002-07       Impact factor: 7.892

3.  Protection against ischemia-reperfusion induced oxidative stress by vitamin E treatment.

Authors:  P Venditti; P Masullo; S Di Meo; C Agnisola
Journal:  Arch Physiol Biochem       Date:  1999-02       Impact factor: 4.076

4.  The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass.

Authors:  N J Jansen; W van Oeveren; M van Vliet; C P Stoutenbeek; L Eysman; C R Wildevuur
Journal:  Eur J Cardiothorac Surg       Date:  1991       Impact factor: 4.191

5.  Prostaglandin E1 reduces ischemia/reperfusion injury by normalizing nitric oxide and superoxide release.

Authors:  I Huk; V Brovkovych; J Nanobashvili; C Neumayer; P Polterauer; M Prager; S Patton; T Malinski
Journal:  Shock       Date:  2000-08       Impact factor: 3.454

6.  Oral vitamin C attenuates acute ischaemia-reperfusion injury in skeletal muscle.

Authors:  S R Kearns; D Moneley; P Murray; C Kelly; A F Daly
Journal:  J Bone Joint Surg Br       Date:  2001-11

Review 7.  Spinal cord protection during thoracoabdominal aneurysm repair.

Authors:  Koichi Tabayashi
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

8.  Oral vitamin C reduces the injury to skeletal muscle caused by compartment syndrome.

Authors:  S R Kearns; A F Daly; K Sheehan; P Murray; C Kelly; D Bouchier-Hayes
Journal:  J Bone Joint Surg Br       Date:  2004-08

Review 9.  Ischemia/reperfusion injury in kidney transplantation: mechanisms and prevention.

Authors:  M Kosieradzki; W Rowiński
Journal:  Transplant Proc       Date:  2008-12       Impact factor: 1.066

10.  Prevention of ischemic spinal cord injury following aortic cross-clamping: use of corticosteroids.

Authors:  J C Laschinger; J N Cunningham; M M Cooper; K Krieger; I M Nathan; F C Spencer
Journal:  Ann Thorac Surg       Date:  1984-11       Impact factor: 4.330

View more
  8 in total

1.  Hydrocortisone and Ascorbic Acid Synergistically Prevent and Repair Lipopolysaccharide-Induced Pulmonary Endothelial Barrier Dysfunction.

Authors:  Nektarios Barabutis; Vikramjit Khangoora; Paul E Marik; John D Catravas
Journal:  Chest       Date:  2017-07-21       Impact factor: 9.410

2.  Steroids for sepsis: yes, no or maybe.

Authors:  Paul E Marik
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

3.  Hydrocortisone, ascorbic acid and thiamine for sepsis: Is the jury out?

Authors:  Paul Ellis Marik; Joseph Varon; Salim R Surani
Journal:  World J Diabetes       Date:  2020-04-15

4.  Vitamin E supplementation fails to impact measures of oxidative stress or the anaemia of feline chronic kidney disease: a randomised, double-blinded placebo control study.

Authors:  Rebecca M Timmons; Craig B Webb
Journal:  Vet Med Sci       Date:  2016-01-22

5.  Administration of Corticosteroids, Ascorbic Acid, and Thiamine Improves Oxygenation after Thoracoscopic Esophagectomy.

Authors:  Tadashi Matsuoka; Hiroharu Shinozaki; Soji Ozawa; Yoshimitsu Izawa; Kazuo Koyanagi; Alan Kawarai Lefor; Kenji Kobayashi
Journal:  Ann Thorac Cardiovasc Surg       Date:  2019-10-18       Impact factor: 1.520

Review 6.  Hydrocortisone, Ascorbic Acid and Thiamine (HAT Therapy) for the Treatment of Sepsis. Focus on Ascorbic Acid.

Authors:  Paul E Marik
Journal:  Nutrients       Date:  2018-11-14       Impact factor: 5.717

Review 7.  Vitamin C: should we supplement?

Authors:  Angélique M E Spoelstra-de Man; Paul W G Elbers; Heleen M Oudemans-Van Straaten
Journal:  Curr Opin Crit Care       Date:  2018-08       Impact factor: 3.687

8.  Early Vitamin C, Hydrocortisone, and Thiamine Treatment for Septic Cardiomyopathy: A Propensity Score Analysis.

Authors:  Min-Taek Lee; Sun-Young Jung; Moon Seong Baek; Jungho Shin; Won-Young Kim
Journal:  J Pers Med       Date:  2021-06-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.